What is Invega ?

Paliperidone ER (extended-release) is an atypical antipsychotic medication primarily used for the treatment of schizophrenia and schizoaffective disorder. By modulating dopamine and serotonin receptors in the brain, it helps to alleviate symptoms such as hallucinations, delusions, and mood disturbances. The extended-release formulation allows for once-daily dosing, providing more stable symptom control and improving patient adherence.

• drowsiness
• dizziness
• dry mouth
• constipation
• weight gain
• increased heart rate
• nasal congestion
• feeling restless or having trouble sitting still
• tremors
• upset stomach or vomiting
• blurred vision

• Risk of severe allergic reactions such as anaphylaxis
• Increased risk of stroke in elderly patients with dementia-related psychosis
• Potential for increased risk of suicidal thoughts or actions
• Neuroleptic Malignant Syndrome (NMS), a potentially fatal reaction
• Tardive Dyskinesia, a serious movement disorder
• Leukopenia, neutropenia, and agranulocytosis
• Orthostatic hypotension leading to dizziness or fainting
• Hyperglycemia and diabetes mellitus among susceptible individuals
• Seizures
• Dysphagia (difficulty swallowing)
• Priapism, a prolonged erection that can be dangerous